MALE + FEMALE LABS Flashcards

(37 cards)

1
Q

what test is used to dx prostate cancer

A

PSA- prostate specific antigen
- predicts course and stage of ds
- helps to dx but NOT used for routine screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PSA
- used when
- elevated when

A

correlates with size of prostate
- good for dx and suspicion, not routine screen
- test if still elevated after 2-3 months
- elevated in prostate carcinoma and BPH
- inc after exams or biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

testicular cancer
- types and subtypes
- labs

A

germ cell tumors (MC)
- seminomas
- non seminomatous germ cell

sex cord/stromal tumors
- leydig
- sertoli

LABS
- hCG, AFP, LD (LD-1)

R stays more localized, but L can go further due to venous/lymphatics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

bladder cancer
- Sx
- MCC
- Dx/labs

A

SS
- painless hematuria
- asx, further growth into mucosal layer and blood supply

MCC
- smoking

Dx
- urine cytology for cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

gonadal dysfunction
- define
- what levels are influenced

A

partial androgen deficiency
- occurs when testosterone levels dec with age (adv age andropause)
- dec testosterone, normal gonadotropin levels (GnRH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

gonadal dysfunction
- SS
- tested when

A

SS
- mood changes
- sexual dysfunc
- dec RBC production
- dec muscle, hair growth

dx/labs
- tested when SS are present, not routine screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

gonadal dysfunc- partial androgen deficiency
- tx effects
- side effects

A

tx
- replacement will inc muscle mass, bone mass, protect against falls and reduce bone fractures

side effects
- patho of BPH (inc sx) and prostate ca, dec sperm count, dyslipidemia, inc CAD

DO NOT GIVE TO CAD!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

gonadal dysfunc
- low v. high LH

A

low LH–> pituitary or hypothalamic problem

high LH–> secondary cause of low androgen level (meds, hypothyroid, anabolic steroids)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

infertility
- define and causes

A

failure to conceive after 1 yr
causes
- production or blockage issue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

infertility testing

A

semen analysis
- 2-5 days of abstinence
- testing viscosity, completeness of liquefaction, appearance, pH
- motility pattern (beating flagella and progressive motility)
- viability
- sperm agglut/antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MCC of cervical cancer

A

HPV
- certain strains have higher risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cervical cancer screening- pap smear
- ages 21-29
- 30-65
- <21 or >65 w/prior screening, and women who have had a hysterectomy

A

21-29
- GRADE A: screen every 3 yrs w cytology

30-65
- GRADE A: screen every 3 yrs w cytology, every 5 yrs w hrHPV testing alone, OR every 5 yrs with cotesting

<21 or >65 w/prior screening, and women who have had a hysterectomy
- GRADE D: do not screen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pregnancy testing and timing

A

urine hCG
- 14 days post conception

beta hCG
- 8-11 days post conception
- double every 1.5-2 days for the first 8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

maternal serum screening

A

test for fetal abnormalities
- neural tube defects
- trisomy 21/down’s
- trisomy 18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

maternal serum screening
- 1st and 2nd trimester work up
- 2nd trimester trisomy 18 v. 21 levels

A

1st (approx 12 wks)
- AFP, hCG, PAPP (pregnancy assoc plasma protein), nucal ultrasound

2nd
- AFP, hCG, estriol, inhibin A
- trisomy 18–> all will appear low
- trisomy 21–> AFP and estriol low, hCG and inihibin A elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

common fetal abnormalities

A
  • small mouth, jaw
  • short neck
  • shield chest or short prominent sternum
  • wide set nipples
  • occiput is prominent
  • dysplastic or malformed ears
  • clenched hands w overlapping fingers
  • flexed big toe, prominent heels
17
Q

maternal serum screening

fetal DNA screening
- testing for what
- recommended for

A

testing
- maternal serum
- does not tell of neural tube defects (must use US)
- gender
- chromosomal abnorm

recommended for
- mother >35 yo (geriatric)
- US suggested
- previous pregnancies
- lab abnormalities

18
Q

ectopic pregnancy
- complications that inc risk

A

pregnancy outside of uterus
- can cause maternal death
- inc risk with tubal damage (infx), smoking, infertility, previous ectopic preg

ALWAYS work up if susepcting ectopic pregnancy

19
Q

ectopic pregnancy
- Sx
- work up
- tx

A

Sx
- low abd pain, vaginal bleeding, adnexal mass

Work up
- transvaginal US, hCG levels (beta doubling time might rise)

tx
- methotrexate or surgical intervention

20
Q

spontaneous abortion
- contributing factors

A

miscarriage
- 10-20% of pregnancies at <20 wks

contributing factors
- maternal age, previous, smoking, ETOH, drugs

21
Q

spontaneous abortion
- potential causes

A
  • secondary to chromosomal abnormalities
  • recurrent if 3 or more consecutive
22
Q

trophoblastic (GTD- gestational trophoblastic ds)
- define
- dx
- tx

A

ds process of placenta, CAN develop into malignancy

dx
- no fetal heart beat, elevatd hCG, shortened/rapid hCG doubling

tx
- dilation and excision (D&E), follow post surgical hCG to ensure reduction

trophoblasts develop into placental layer

23
Q

trophoblastic ds hCG post D&E

A

hCG SHOULD fall to zero
- if it doesnt drop, can indicate there is still presence of trophoblastic tissue or cancer

24
Q

preeclampsia/eclampsia
- difference in presentation
- additional findings

A

pre: HTN and proteinuria
eclampsia: HTN, proteinuria, AND SEIZURES

SS
- coagulopathies
- elevated liver enz
- renal failure
- cerebral ischemia

CONTROL SX till delivery

25
HELLP syndrome - SS - occurs when
H- hemolysis E&L- elevated liver enz L&P- low platelets - occur 27-36 wks - can occur w/preeclampsia
26
fatty liver in pregnancy - SS and when does it happen - labs - dx
SS - n/v, RUQ pain, lethargy - occutrs approx 36 weeks labs - AST>ALT - elevated bilirubin, PTT, PT - hyperuricemia - hypoglycemia - dec fibrogen dx - liver bx
27
female infertility causes
ovarian, hormonal, tubal, cervical, uterine, psychosocial, iatrogenic, immunological
28
breast cancer mammogram recommended when - age 50-74 - age 40-49
women aged 50-74 recommended bieenial screening 40-49 if more benefit than harm
29
breast cancer- factors that inc risks
- inc age - fam hx - hormonal hx - clinical density (fibrodense tissue) - obesity - ETOH
30
screening v. diagnostic mammo
- screening used routinely to check for women w/out sx - diagnostic used when symptomatic or abnormal finding with screening mammo (imaging reviewed immed)
31
breast cancer tx
- breast conserving surgery - radiation - masectomy - chemo - hormone therapy
32
breast cancer - prognosis based on
based on - tumor size - axillary node involvement - histological type (tissue) and grade (how dysplastic it is) - lymphatic and vasc invasion - biomarkers
33
breast cancer labs tumor markers and tx
tumor markers - estrogen receptor (70% of breast ca), favorable prognosis - progresterone receptor endocrine treatments - selective ER modulators (estrogen receptor mod): tamoxifen - ovarian ablation
34
breast cancer labs HER-2 and tx
HER-2 - chromosomal gene that regulates cell prolif and survival - gene becomes amplified/overproduced -more aggressive and poor outcome tx - trastuzumab (cardiotoxic)
35
hereditary breast and ovarian cancer - BRCA1 and 2 explain mutation - RFs that suggestion mutation present
hereditary mutation - autosomal dom - mutation in tumor suppressor genes-----> gene stability is deleted RFs suggesting mutation - early breast ca <50 yo, bilat ca, breast and ovarian, breast ca in male relative
36
BRCA 1 v. 2 - risks inc with both mutations v. only 1 or 2
- 1&2- 60-80% ocurrence of breast ca - BRCA 1 has higher risk ovarian than BRCA 2 - both inc risk melanoma, prostate ca, and pancreatic ca
37
hereditary breast and ovarian ca screening/testing
if present - intensive screening - chemoprevention - masectomy - prophylatic oophorectomy--> after childbearing to dec risk (remove ovaries)